← Back to Search

Behavioral Intervention

Pain Reprocessing Therapy for Chronic Knee Pain (REJOICE Trial)

Aurora, CO
N/A
Waitlist Available
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Major surgery or other major medical event planned in the coming 6 months
Self-reported diagnosis of an autoimmune disease: rheumatoid arthritis, polymyalgia rheumatica, scleroderma, Lupus, polymyositis, or other autoimmune disorder
Timeline
Screening 3 weeks
Treatment Varies
Follow Up approximately 12, 18, and 26 weeks post-randomization
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to see if Pain Reprocessing Therapy (PRT) can help adults with knee pain after knee replacement surgery compared to regular care. The study will look at whether PRT can reduce chronic

Who is the study for?
This trial is for adults with chronic knee pain after knee replacement surgery. Participants will be randomly assigned to receive either Pain Reprocessing Therapy (PRT) or usual post-surgery care and must be willing to complete questionnaires and possibly undergo an EEG test.
What is being tested?
The study aims to determine if PRT can reduce chronic knee pain more effectively than the usual care following knee surgery. It involves eight weekly therapy sessions via video calls and measures outcomes like pain relief, anxiety, depression, sleep quality, and brain activity related to pain.
What are the potential side effects?
Since PRT is a psychological therapy involving no medication or invasive procedures, side effects are minimal but may include temporary increases in emotional distress due to discussing painful experiences.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not have any major surgeries or medical events planned in the next 6 months.
Select...
I have been diagnosed with an autoimmune disease like rheumatoid arthritis or Lupus.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~approximately 12, 18, and 26 weeks post-randomization
This trial's timeline: 3 weeks for screening, Varies for treatment, and approximately 12, 18, and 26 weeks post-randomization for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Pain intensity
Secondary study objectives
Anxiety
Depression
Fatigue
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Usual CareExperimental Treatment1 Intervention
Participants will be asked to continue whatever they are already doing to care for their knee pain. Length of the usual care condition will be eight weeks, the expected mean completion time of the PRT arm, and may be adjusted at mid-enrollment to match treatment arm length more closely.
Group II: Pain reprocessing therapy (PRT)Experimental Treatment1 Intervention
PRT has five components: 1) education about the origin of pain in the brain, its reversibility, and the pain-fear cycle; 2) reinforcing education using personal biography; 3) "somatic tracking" of pain through mindfulness and reappraisal of pain sensations as non-dangerous; 4) lowering the level of personal threat that may trigger pain sensation; and 5) inducing positive affect in periods of pain. Patients will attend one assessment and education telehealth session with a physician followed by eight 50-minute, therapist-led sessions. Pacing will be weekly, for approximately eight weeks.Treatment will be provided by experienced PRT clinicians. All PRT sessions will be remotely delivered.

Find a Location

Closest Location:University of Colorado Anschutz Medical Campus· Aurora, CO

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor
1,832 Previous Clinical Trials
3,025,824 Total Patients Enrolled
Weill Medical College of Cornell UniversityOTHER
1,101 Previous Clinical Trials
1,157,094 Total Patients Enrolled
Hospital for Special Surgery, New YorkOTHER
252 Previous Clinical Trials
61,157 Total Patients Enrolled
~73 spots leftby Sep 2026